This menu provides the list of EV miRNAs identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Maximum false positive rate (FPR): Maximum true positive rate (TPR):
  - FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
  - TPR is the percentile of miRNA among the present miRNAs.
    Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.

Mature name miRBase accession FPR TPR Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-17-5pMIMAT0000070 0.0e+0 2.9e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000001_199 / 0 / 99
hsa-miR-183-5pMIMAT0000261 0.0e+0 5.0e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000066_139 / 0 / 39
hsa-miR-188-5pMIMAT0000457 0.0e+0 4.0e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000113_177 / 0 / 77
hsa-miR-188-5pMIMAT0000457 0.0e+0 4.0e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000113_177 / 0 / 77
hsa-miR-1915-3pMIMAT0007892 0.0e+0 2.7e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0001037_251 / 0 / 51
hsa-miR-1915-3pMIMAT0007892 0.0e+0 2.5e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0001037_251 / 0 / 51
hsa-miR-192-5pMIMAT0000222 0.0e+0 2.9e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000063_155 / 0 / 55
hsa-miR-192-5pMIMAT0000222 0.0e+0 3.6e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000063_155 / 0 / 55
hsa-miR-193b-3pMIMAT0002819 0.0e+0 3.2e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000082_247 / 0 / 47
hsa-miR-197-5pMIMAT0022691 0.0e+0 1.9e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000123_121 / 0 / 21
hsa-miR-197-5pMIMAT0022691 0.0e+0 1.6e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000123_121 / 0 / 21
hsa-miR-1973MIMAT0009448 0.0e+0 4.4e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		Not available15 / 0 / 15
hsa-miR-1973MIMAT0009448 0.0e+0 2.1e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		Not available15 / 0 / 15
hsa-miR-19a-3pMIMAT0000073 0.0e+0 4.0e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000011_275 / 0 / 75
hsa-miR-19a-3pMIMAT0000073 0.0e+0 4.3e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 2.8e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000011_275 / 0 / 75
hsa-miR-19b-3pMIMAT0000074 0.0e+0 3.4e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000011_275 / 0 / 75
hsa-miR-20a-5pMIMAT0000075 0.0e+0 2.5e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000001_199 / 0 / 99
hsa-miR-20a-5pMIMAT0000075 0.0e+0 3.0e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000001_199 / 0 / 99
hsa-miR-20b-5pMIMAT0001413 0.0e+0 3.7e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000001_199 / 0 / 99
hsa-miR-21-5pMIMAT0000076 0.0e+0 1.0e-2Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000060_187 / 0 / 87
hsa-miR-21-5pMIMAT0000076 0.0e+0 2.7e-2Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000060_187 / 0 / 87
hsa-miR-211-3pMIMAT0022694 0.0e+0 4.8e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000042_233 / 0 / 33
hsa-miR-211-3pMIMAT0022694 0.0e+0 4.9e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000042_233 / 0 / 33
hsa-miR-215-5pMIMAT0000272 0.0e+0 3.8e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000063_155 / 0 / 55
hsa-miR-215-5pMIMAT0000272 0.0e+0 4.0e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000063_155 / 0 / 55
hsa-miR-22-3pMIMAT0000077 0.0e+0 2.4e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000053_270 / 0 / 70
hsa-miR-22-3pMIMAT0000077 0.0e+0 3.4e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000053_270 / 0 / 70
hsa-miR-221-3pMIMAT0000278 0.0e+0 4.3e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000051_251 / 0 / 51
hsa-miR-223-3pMIMAT0000280 0.0e+0 4.7e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000067_252 / 0 / 52
hsa-miR-224-5pMIMAT0000281 0.0e+0 2.7e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000088_115 / 0 / 15
hsa-miR-224-5pMIMAT0000281 0.0e+0 2.2e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000088_115 / 0 / 15
hsa-miR-2276-3pMIMAT0011775 0.0e+0 4.1e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		Not available19 / 0 / 19
hsa-miR-2276-3pMIMAT0011775 0.0e+0 3.9e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		Not available19 / 0 / 19
hsa-miR-2392MIMAT0019043 0.0e+0 4.3e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0001614_114 / 0 / 14
hsa-miR-2392MIMAT0019043 0.0e+0 3.3e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0001614_114 / 0 / 14
hsa-miR-23a-3pMIMAT0000078 0.0e+0 1.8e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000027_2102 / 0 / 102
hsa-miR-23a-3pMIMAT0000078 0.0e+0 8.0e-2Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000027_2102 / 0 / 102
hsa-miR-23b-3pMIMAT0000418 0.0e+0 2.5e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000027_2102 / 0 / 102
hsa-miR-23b-3pMIMAT0000418 0.0e+0 4.1e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000027_2102 / 0 / 102
hsa-miR-24-3pMIMAT0000080 0.0e+0 2.4e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000041_259 / 0 / 59
hsa-miR-24-3pMIMAT0000080 0.0e+0 2.6e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000041_259 / 0 / 59
hsa-miR-25-3pMIMAT0000081 0.0e+0 2.3e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000013_273 / 0 / 73
hsa-miR-25-3pMIMAT0000081 0.0e+0 3.0e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000013_273 / 0 / 73
hsa-miR-26a-5pMIMAT0000082 0.0e+0 4.6e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000043_169 / 0 / 69
hsa-miR-27a-3pMIMAT0000084 0.0e+0 3.3e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000036_280 / 0 / 80
hsa-miR-27a-3pMIMAT0000084 0.0e+0 2.6e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000036_280 / 0 / 80
hsa-miR-27b-3pMIMAT0000419 0.0e+0 2.4e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000036_280 / 0 / 80
hsa-miR-27b-3pMIMAT0000419 0.0e+0 1.7e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000036_280 / 0 / 80
hsa-miR-2861MIMAT0013802 0.0e+0 2.5e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000963_147 / 0 / 47
hsa-miR-2861MIMAT0013802 0.0e+0 1.7e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000963_147 / 0 / 47
hsa-miR-29a-3pMIMAT0000086 0.0e+0 4.8e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000009_262 / 0 / 62
hsa-miR-29a-3pMIMAT0000086 0.0e+0 2.3e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000009_262 / 0 / 62
hsa-miR-29b-3pMIMAT0000100 0.0e+0 4.5e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000009_262 / 0 / 62
hsa-miR-30a-5pMIMAT0000087 0.0e+0 4.1e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000005_189 / 0 / 89
hsa-miR-30a-5pMIMAT0000087 0.0e+0 3.2e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000005_189 / 0 / 89
hsa-miR-30d-5pMIMAT0000245 0.0e+0 3.9e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000005_189 / 0 / 89
hsa-miR-30d-5pMIMAT0000245 0.0e+0 4.4e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000005_189 / 0 / 89
hsa-miR-3141MIMAT0015010 0.0e+0 4.2e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		Not available36 / 0 / 36
hsa-miR-3141MIMAT0015010 0.0e+0 4.2e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		Not available36 / 0 / 36
hsa-miR-3156-5pMIMAT0015030 0.0e+0 3.6e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000891_116 / 0 / 16
hsa-miR-3156-5pMIMAT0015030 0.0e+0 4.1e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000891_116 / 0 / 16
hsa-miR-3162-5pMIMAT0015036 0.0e+0 2.2e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		Not available34 / 0 / 34
hsa-miR-3162-5pMIMAT0015036 0.0e+0 2.1e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		Not available34 / 0 / 34
hsa-miR-3195MIMAT0015079 0.0e+0 4.2e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		Not available24 / 0 / 24
hsa-miR-3196MIMAT0015080 0.0e+0 4.0e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		Not available36 / 0 / 36
hsa-miR-3196MIMAT0015080 0.0e+0 3.5e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		Not available36 / 0 / 36
hsa-miR-320aMIMAT0000510 0.0e+0 2.8e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000163_183 / 0 / 83
hsa-miR-320aMIMAT0000510 0.0e+0 2.1e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000163_183 / 0 / 83
hsa-miR-320bMIMAT0005792 0.0e+0 2.9e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000163_183 / 0 / 83
hsa-miR-320bMIMAT0005792 0.0e+0 1.8e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000163_183 / 0 / 83
hsa-miR-320cMIMAT0005793 0.0e+0 1.2e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000163_183 / 0 / 83
hsa-miR-320cMIMAT0005793 0.0e+0 9.7e-2Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000163_183 / 0 / 83
hsa-miR-320dMIMAT0006764 0.0e+0 2.1e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000163_183 / 0 / 83
hsa-miR-320dMIMAT0006764 0.0e+0 1.6e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000163_183 / 0 / 83
hsa-miR-320eMIMAT0015072 0.0e+0 2.4e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000163_183 / 0 / 83
hsa-miR-320eMIMAT0015072 0.0e+0 1.7e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000163_183 / 0 / 83
hsa-miR-335-5pMIMAT0000765 0.0e+0 3.7e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000196_124 / 0 / 24
hsa-miR-34a-5pMIMAT0000255 0.0e+0 4.6e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000039_151 / 0 / 51
hsa-miR-34a-5pMIMAT0000255 0.0e+0 3.8e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000039_151 / 0 / 51
hsa-miR-3648MIMAT0018068 0.0e+0 4.6e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0001984_126 / 0 / 26
hsa-miR-3648MIMAT0018068 0.0e+0 4.3e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0001984_126 / 0 / 26
hsa-miR-3656MIMAT0018076 0.0e+0 2.5e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		Not available43 / 0 / 43
hsa-miR-3656MIMAT0018076 0.0e+0 2.4e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		Not available43 / 0 / 43
hsa-miR-365a-3pMIMAT0000710 0.0e+0 3.6e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000061_235 / 0 / 35
hsa-miR-365a-3pMIMAT0000710 0.0e+0 3.5e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000061_235 / 0 / 35
hsa-miR-365b-5pMIMAT0022833 0.0e+0 4.9e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000061_114 / 0 / 14
hsa-miR-3663-3pMIMAT0018085 0.0e+0 4.8e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		Not available19 / 0 / 19
hsa-miR-3665MIMAT0018087 0.0e+0 2.2e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		Not available39 / 0 / 39
hsa-miR-3665MIMAT0018087 0.0e+0 1.7e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		Not available39 / 0 / 39
hsa-miR-3667-5pMIMAT0018089 0.0e+0 4.0e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		Not available11 / 0 / 11
hsa-miR-3667-5pMIMAT0018089 0.0e+0 3.7e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		Not available11 / 0 / 11
hsa-miR-3679-5pMIMAT0018104 0.0e+0 2.9e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		Not available23 / 0 / 23
hsa-miR-3679-5pMIMAT0018104 0.0e+0 2.1e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		Not available23 / 0 / 23
hsa-miR-371a-5pMIMAT0004687 0.0e+0 4.9e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 1.2e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 2.0e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000068_147 / 0 / 47
hsa-miR-371a-5pMIMAT0004687 0.0e+0 2.3e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 0.0e+0 3.5e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000068_147 / 0 / 47
hsa-miR-371b-5pMIMAT0019892 0.0e+0 3.5e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000068_147 / 0 / 47
< [570] [571] [572] [573] [574] [575] [576] [577] [578] [579] >